Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Biochimica Et Biophysica Acta|June 10, 2010
P2X7 receptor activation induces cell death and microparticle release in murine erythroleukemia cellsPatrick Constantinescu, Bin Wang, Kati Kovacevic, et al.
Dalton Transactions (Cambridge, England : 2003)|July 17, 2024
Effect of substituents on the ability of nickel Schiff base complexes with four pendant groups to bind to G-quadruplexesNawal Assadawi, Myles Ferderer, Nicholas Kusi-Appauh, et al.
Analytical Chemistry|August 9, 2017
On-Chip Microparticle and Cell Washing Using Coflow of Viscoelastic Fluid and Newtonian FluidDan Yuan, Say Hwa Tan, Ronald Sluyter, et al.
IEEE Transactions on Biomedical Circuits and Systems|September 4, 2017
High-Throughput Separation of White Blood Cells From Whole Blood Using Inertial MicrofluidicsJun Zhang, Dan Yuan, Ronald Sluyter, et al.
Biochimica Et Biophysica Acta|July 31, 2010
TGF-β1 prevents up-regulation of the P2X7 receptor by IFN-γ and LPS in leukemic THP-1 monocytesSafina Gadeock, Jimmy N S N Tran, Jennifer G Georgiou, et al.
The Journal of Investigative Dermatology|August 25, 2005
Human epidermal and monocyte-derived langerhans cells express functional P2X receptorsJennifer G Georgiou, Kristen K Skarratt, Stephen J Fuller, et al.
Critical Reviews in Toxicology|April 6, 2019
Nano-sunscreens - a double-edged sword in protecting consumers from harm: viewing Australian regulatory policies through the lenses of the European UnionS M Solaiman, Jennifer Algie, Shahnaz Bakand, et al.
European Journal of Nutrition|May 29, 2026
Microencapsulated docosahexaenoic acid increases the Omega-3 Index and attenuates the physiological impact of eccentric exercise in physically trained adults: a 12-week double-blind placebo-controlled trialRyan Anthony, Michael J Macartney, Peter L McLennan, et al.
Clinical & Translational Immunology|March 18, 2024
Graft-versus-leukaemia immunity is retained following treatment with post-transplant cyclophosphamide alone or combined with tocilizumab in humanised miceChloe Sligar, Ellie Reilly, Peter Cuthbertson, et al.
Immunology and Cell Biology|May 16, 2023
Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft-versus-host disease development in humanized mice treated with post-transplant cyclophosphamideChloe Sligar, Peter Cuthbertson, Nicole A Miles, et al.
Pageof 12